32 min listen
COVID-19: Which Drug, When, and Why? Monoclonal Antibody Treatments
COVID-19: Which Drug, When, and Why? Monoclonal Antibody Treatments
ratings:
Length:
30 minutes
Released:
Apr 21, 2022
Format:
Podcast episode
Description
The place of monoclonal antibodies in COVID-19 is changing. In this episode, learn about their role in prophylaxis of patients who are at high risk of complications from acquiring COVID-19 or treatment of high-risk patients who have a mild to moderate COVID-19 infection. Listen as Gregory Huhn, MD, MPHTM, discusses when and how to use monoclonal antibodies including:BebtelovimabCilgavimab/tixagevimabSotrovimabPresenter:Gregory Huhn, MD, MPHTMAssociate ProfessorDepartment of Infectious DiseasesRush University Medical CenterSenior Director of HIV ServicesDepartment of Infectious DiseasesCook County HealthChicago, IllinoisReview the downloadable slidesets at: https://bit.ly/3xOfu1ALink to full program: https://bit.ly/3EBdf38
Released:
Apr 21, 2022
Format:
Podcast episode
Titles in the series (100)
COVID-19: Answering the Questions, Part 11: In Part 11 of this ongoing COVID-19 series, listen to a brief update on the role of interferons in COVID-19 by Sharon R. Lewin AO, FRACP, PhD, FAHMS. by CCO Infectious Disease Podcast